GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Cosmo Bio Co 3386.T · JPY

Health Care · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

1,218

+0.25%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in JPY, from our data supplier.

FY2025

Revenue

¥10.77bn

FY2016FY2025

Net income

¥336.0m

FY2016FY2025

Free cash flow

¥366.0m

FY2016FY2025

Shareholders' equity

¥9.37bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue¥10.77bn¥10.04bn¥9.34bn¥9.55bn¥9.23bn¥8.09bn¥7.59bn¥7.26bn¥7.07bn¥7.43bn
Gross profit¥3.70bn¥3.33bn¥3.25bn¥3.44bn¥3.66bn¥3.15bn¥2.88bn¥2.66bn¥2.53bn¥2.77bn
Research and development—¥83.0m¥73.0m¥82.0m¥70.0m¥80.0m¥81.0m—¥96.0m¥43.0m
Operating income¥342.0m¥318.0m¥519.0m¥816.0m¥1.05bn¥752.0m¥406.0m¥329.0m¥194.0m¥438.0m
Net income¥336.0m¥262.0m¥442.0m¥517.0m¥737.0m¥674.0m¥237.0m¥260.0m¥237.0m¥255.0m
Diluted earnings per share59.2745.5875.7488.93127.25113.7039.9843.8639.9844.60

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets¥12.66bn¥11.72bn¥10.87bn¥10.31bn¥10.07bn¥9.64bn¥8.89bn¥8.50bn¥8.13bn¥7.93bn
Cash and short-term investments¥2.95bn¥2.69bn¥3.02bn¥3.04bn¥3.56bn¥3.26bn¥2.52bn¥2.27bn¥1.48bn¥1.95bn
Total liabilities¥2.70bn¥2.17bn¥1.84bn¥1.69bn¥1.75bn¥1.78bn¥1.57bn¥1.45bn¥1.29bn¥1.35bn
Debt¥20.0m¥22.0m¥24.0m¥27.0m¥28.0m¥20.0m¥20.0m¥20.0m¥20.0m¥20.0m
Shareholders' equity¥9.37bn¥8.97bn¥8.45bn¥8.05bn¥7.79bn¥7.36bn¥6.84bn¥6.58bn¥6.38bn¥6.13bn
Shares outstanding6m6m6m6m6m6m6m6m6m6m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations¥595.0m¥241.0m¥736.0m¥284.0m¥648.0m¥803.0m¥569.0m¥908.0m¥89.0m¥572.0m
Capital spending−¥229.0m−¥216.0m−¥100.0m−¥104.0m−¥141.0m−¥65.0m−¥182.0m−¥51.0m−¥479.0m−¥252.0m
Free cash flow¥366.0m¥25.0m¥636.0m¥180.0m¥507.0m¥738.0m¥387.0m¥857.0m−¥390.0m¥320.0m
Dividends paid−¥348.0m−¥175.0m−¥197.0m−¥232.0m−¥223.0m−¥94.0m−¥82.0m−¥82.0m−¥106.0m−¥94.0m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue¥2.58bn¥3.33bn¥2.88bn¥2.48bn¥2.31bn¥3.09bn¥2.63bn¥2.28bn
Gross profit¥905.0m¥1.14bn¥965.0m¥871.0m¥807.0m¥1.06bn¥858.0m¥758.0m
Operating income¥9.0m¥272.0m¥67.0m—¥2.0m¥274.0m−¥51.0m¥47.0m
Net income¥54.0m¥223.0m¥63.0m¥23.0m¥37.0m¥213.0m−¥29.0m¥33.0m
Diluted earnings per share9.4539.0111.114.066.5337.57-5.055.74
Total assets¥12.84bn¥12.54bn¥12.66bn¥12.27bn¥11.79bn¥11.52bn¥11.72bn¥11.33bn
Cash and short-term investments¥4.07bn¥3.24bn¥2.95bn¥3.19bn¥3.19bn¥2.50bn¥2.69bn¥3.04bn
Debt¥20.0m¥20.0m¥20.0m¥20.0m¥20.0m¥20.0m¥21.0m¥20.0m
Shareholders' equity¥9.76bn¥9.46bn¥9.37bn¥9.28bn¥9.08bn¥8.76bn¥8.97bn¥8.89bn

Financial ratios

Data as of 9 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Gross margin34.4%33.2%34.8%36.0%39.6%39.0%—
Operating margin3.2%3.2%7.0%8.3%11.9%12.5%—
Net margin3.1%2.6%4.7%5.4%8.0%8.3%—
Return on equity3.6%2.9%5.2%6.4%9.5%9.2%—
Return on assets2.7%2.2%4.1%5.0%7.3%7.0%—
Free cash flow yield11.7%6.4%11.5%5.4%11.0%11.8%—
Revenue growth7.3%7.5%-2.2%3.5%14.1%6.6%—
Earnings growth28.2%-40.7%-14.5%-29.9%9.3%184.4%—
Current ratio5.23x6.20x6.32x6.87x6.69x5.51x—
Debt to equity0.00x0.00x0.00x0.00x0.00x0.00x—
Equity ratio74.0%76.5%77.7%78.1%77.3%76.3%—
R&D as a share of sales—0.8%0.8%0.9%0.8%1.0%1.1%
Buybacks as a share of market value1.4%1.5%-0.4%-0.4%2.3%0.0%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue4.1%5.9%3.9%
Operating income-25.2%-14.6%5.5%
Net income-13.4%-13.0%3.9%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin33.8%34.6%36.0%36.0%
Operating margin3.2%5.0%6.7%5.7%
Net margin2.9%3.9%5.2%4.5%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings22.023.713.011.49.110.826.220.028.028.1
Price to sales0.70.60.60.60.70.90.80.70.91.0

Dividends and splits

Per share, in the currency the company pays

Paid for 21 years. Last went ex-dividend on 29 Dec 2025.

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Paid in the year86.0030.0034.0040.0038.0016.0014.0014.00
  • 100-for-1 split · 26 Dec 2012
  • 2-for-1 split · 26 Sept 2006
  • 1-to-1 reverse split · 1 Dec 2000

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.